- Home
- APYX vs SYRS Comparison
APYX vs SYRS Comparison
Compare APYX & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APYX
- SYRS
- Stock Information
- Founded
- APYX 1982
- SYRS 2011
- Country
- APYX United States
- SYRS United States
- Employees
- APYX N/A
- SYRS N/A
- Industry
- APYX Medical/Dental Instruments
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- APYX Health Care
- SYRS Health Care
- Exchange
- APYX Nasdaq
- SYRS Nasdaq
- Market Cap
- APYX 42.3M
- SYRS 7.1M
- IPO Year
- APYX 1987
- SYRS 2016
- Fundamental
- Price
- APYX $1.57
- SYRS $0.22
- Analyst Decision
- APYX Hold
- SYRS Hold
- Analyst Count
- APYX 2
- SYRS 5
- Target Price
- APYX N/A
- SYRS $3.00
- AVG Volume (30 Days)
- APYX 68.8K
- SYRS 2.6M
- Earning Date
- APYX 11-08-2024
- SYRS 10-31-2024
- Dividend Yield
- APYX N/A
- SYRS N/A
- EPS Growth
- APYX N/A
- SYRS N/A
- EPS
- APYX N/A
- SYRS N/A
- Revenue
- APYX $48,542,000.00
- SYRS $386,000.00
- Revenue This Year
- APYX N/A
- SYRS N/A
- Revenue Next Year
- APYX $2.78
- SYRS $1,011.11
- P/E Ratio
- APYX N/A
- SYRS N/A
- Revenue Growth
- APYX N/A
- SYRS N/A
- 52 Week Low
- APYX $0.97
- SYRS $0.18
- 52 Week High
- APYX $2.80
- SYRS $8.17
- Technical
- Relative Strength Index (RSI)
- APYX 50.85
- SYRS 29.17
- Support Level
- APYX $1.46
- SYRS $0.19
- Resistance Level
- APYX $1.72
- SYRS $0.21
- Average True Range (ATR)
- APYX 0.20
- SYRS 0.02
- MACD
- APYX -0.03
- SYRS 0.07
- Stochastic Oscillator
- APYX 30.91
- SYRS 20.53
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.